Answers are grounded in this paper and cite their sources.
Anemia is common in patients with acute coronary syndromes, but whether its prognostic significance varies according to age remains uncertain. We retrospectively analyzed 8,684 consecutive patients admitted with acute coronary syndromes to 2 tertiary hospitals in Spain. Baseline hemoglobin and anemia were evaluated in relation to in-hospital mortality, heart failure, and major bleeding, and to long-term all-cause mortality, cardiovascular mortality, heart failure hospitalization, and major bleeding. Multivariable logistic, Cox regression, and competing-risk models were used. Interactions between age and hemoglobin or anemia were assessed. Median hemoglobin was 14.0 g/dL, and 21.8% of patients had anemia. Lower hemoglobin was independently associated with higher risks of in-hospital mortality, heart failure, and major bleeding. During a median follow-up of 58 months, lower hemoglobin and anemia were associated with all-cause mortality, cardiovascular mortality, heart failure hospitalization, and major bleeding. Significant interactions were observed between age and both hemoglobin and anemia. The excess risk associated with lower hemoglobin and anemia progressively decreased with advancing age and was markedly attenuated in patients aged ≥75 years. In conclusion, hemoglobin and anemia are independent predictors of adverse outcomes after acute coronary syndromes, but their long-term prognostic significance is strongly modified by age. Their association with adverse events is substantially greater in younger patients and attenuated in those aged ≥75 years.
No takes yet. Share an insight, caveat, or question.
Cordero et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: